Biolidics Overview

  • Founded
  • 2009

Founded
  • Status
  • Public

  • Employees
  • 26

Employees
  • Stock Symbol
  • 8YY

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.01

  • (As of Friday Closing)

Biolidics General Information

Description

Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; and Laboratory services. It derives major revenue from the infectious diseases segment that involves the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the infectious diseases field. Its operations are spread across Singapore, Japan, China, Europe, United States, Hong Kong, Philippines, Indonesia, and Others.

Contact Information

Formerly Known As
Clearbridge BioMedics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Stock Exchange
SES
Primary Office
  • 37 Jalan Pemimpin
  • Number 02-07
  • Mapex, 577177
  • Singapore

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolidics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.09 $6.28M 522M 4.98M -$0.01

Biolidics Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 7,052 35,144 56,205 37,434
Revenue 1,501 1,722 6,456 1,054
EBITDA (2,561) (3,409) (2,600) (3,135)
Net Income (3,587) (4,453) (3,371) (3,525)
Total Assets 4,939 8,448 14,175 7,136
Total Debt 2,298 3,142 3,987 398
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biolidics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biolidics‘s full profile, request access.

Request a free trial

Biolidics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and m
Biotechnology
Mapex, Singapore
26 As of 2018
000.00
000000000 000.00

000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
000000000 00000 (000
San Francisco, CA
000 As of 0000
00000
000000000 00000

00000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
0.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biolidics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Standard BioTools Formerly VC-backed San Francisco, CA 000 00000 000000000 00000
00000 000000000000 Private Equity-Backed Ahmedabad, India 00000 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Biolidics Patents

Biolidics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6924210-B2 Systems and methods for enriching target cells in a sample Active 04-May-2016 000000000000
US-11059042-B2 Systems and methods for enriching target cells in a sample Active 04-May-2016 000000000000
AU-2016405636-A1 Systems and methods for enriching target cells in a sample Active 04-May-2016 000000000000
AU-2016405636-B2 Systems and methods for enriching target cells in a sample Active 04-May-2016 000000000000
EP-3455337-A4 Systems and methods for enriching target cells in a sample Pending 04-May-2016 B01L3/502761 0
To view Biolidics’s complete patent history, request access »

Biolidics Executive Team (13)

Name Title Board Seat Contact Info
Song Yih Chief Executive Officer & Executive Director
Wang Qing-Yin Ph.D Chief Operating Officer
Tan Chee Financial Controller
Man Leong Chief Commercial Officer
Chwee Lim Ph.D Co-Founder & Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

Biolidics Board Members (7)

Name Representing Role Since
Beng Kwan Chia Biolidics Board Member 000 0000
Jeremy Yee Self Co-Chief Executive Officer & Non-Executive Non-Independent Chairman 000 0000
Johnson Chen Self Board Member & Founder 000 0000
Tony Qian Biolidics Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Biolidics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolidics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biolidics‘s full profile, request access.

Request a free trial

Biolidics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 26-May-2020 0000000000 00.000 Laboratory Services (Healthcare)
To view Biolidics’s complete acquisitions history, request access »

Biolidics Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000000 Laboratory Services (Healthcare) Singapore, Singapore 0000
To view Biolidics’s complete subsidiaries history, request access »

Biolidics ESG

Risk Overview

Risk Rating

Updated February, 21, 2023

35.45 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,231

Rank

00.00

Percentile

Healthcare

Industry

00 of 601

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 207

Rank

00.00

Percentile

To view Biolidics’s complete esg history, request access »